Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × Dexamethasone × Clear all

NCT02843074 2023-12-05

Elotuzumab, Lenalidomide and Dexamethasone in Treatment of Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients

Phase 2 Completed

53 enrolled 14 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

NCT03121534 2023-02-17

Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation

Phase 2 Terminated

9 enrolled 10 charts

Other hematologic neoplasm

Hematologic Neoplasms

NCT00742560 2018-01-10

A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma

Phase 2 Completed

101 enrolled 20 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms